SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

NASAs CLPS 2.0 lunar-services awards are the main focus, with traders celebrating Intuitive Machines selection as a vendor and speculating that the program could materially expand its backlog. The reaction is broadly bullish, though some note that multiple companies were selected and the size and revenue impact of LUNRs awards remain uncertain.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus Q3 results beat expectations and the company raised its full-year revenue outlook, prompting a bullish post-earnings reaction and increased interest in call options. Traders are debating whether the momentum can continue, while others point to the stocks volatility and questions about healthcare adoption and execution.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense and Space Technologies, and Starlab Space Stations. The Defense and Space Technologies segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager is drawing attention after reporting sharply higher quarterly revenue and bookings, raising its full-year outlook, and highlighting a major NASA award. Traders are reacting to the growth and backlog, while some remain cautious about profitability and the stocks history of fading positive news.

American Express Co. engages in the provision of card-issuing, merchant-acquiring, and card network businesses. Its products and services include credit cards, business credit cards, corporate programs, gift cards, savings accounts and CDs, and the American Express App. It operates through the following segments: the United States Consumer Services (USCS), Commercial Services (CS), International Card Services (ICS), Global Merchant and Network Services (GMNS), and Corporate and Other. The USCS segment includes proprietary consumer cards and provides services to United States consumers. The CS segment offers corporate and small business cards and provides services to United States businesses. The ICS segment provides consumers, small businesses, and corporate cards outside the United States. The GMNS segment is involved in operating a global payments network that processes and settles card transactions, acquires merchants, and provides multi-channel marketing programs and capabilities, services and data analytics. The Corporate and Other segment covers corporate functions and certain other businesses and operations. It also operates through the following geographical segments: United States, EMEA, APAC, LACC, and Other. The EMEA segment represents Europe, the Middle East, and Africa. The APAC segment refers to Asia Pacific, Australia, and New Zealand. The LACC segment focuses on Latin America, Canada, and the Caribbean. The Other segment includes net costs which are not directly allocated to specific geographic regions. The company was founded by Henry Wells, William G. Fargo, and John Warren Butterfield on March 28, 1850 and is headquartered in New York, NY.

American Express Co.

American Express beat earnings expectations and raised its full-year outlook, but shares sold off as investors focused on planned workforce cuts tied to an AI-focused restructuring and a slight revenue miss. Traders debate whether the reaction is an overreaction or reflects concerns about consumer spending and business momentum.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter results, driven by growth in Dupixent and Eylea HD, sparked a sharp rally and fresh 52-week highs. Traders are broadly upbeat about the earnings beat, while some are weighing whether the run can continue or whether options activity signals hedging or profit-taking.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

Cathie Woods active portfolio rotations are fueling debate around ARKK: critics point to its long-term underperformance and volatile growth-stock exposure, while bulls see signs of a technical recovery and renewed momentum.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimunes FDA approval of TUDRIQEV has shifted attention to its U.S. launch and early physician uptake, amid a sharp rally and heavy call-option interest. Bulls point to launch momentum and a possible short squeeze, while skeptics question whether commercial demand can justify the valuation and ease cash-burn concerns.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios Q3 results beat expectations and full-year outlook rose, but a softer Q4 organic-growth forecast signaled a slowdown from the prior quarter and drove a sharp selloff. Traders are debating whether the drop is an overreaction with a potential bounce or a further repricing for slower growth, while some also question how much AI-driven communications traffic will translate into revenue.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires Q3 results are drawing attention, with weaker operating performanceespecially insurance underwritingset against sharply increased share repurchases. Traders are split between viewing the buybacks and large cash reserves as a sign of confidence and worrying that insurance softness and limited investment opportunities could weigh on results.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

Traders are focused on Northlands upgrade of C3.ai, which cited its C3 Code platform for building agentic AI applications as a potential growth driver. Call-option activity and short-squeeze hopes are adding to the bullish chatter, while skeptics point to weak revenue trends and question whether the turnaround can deliver.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nyxoah SA (NYXH) Reports Q3 Loss, Lags Revenue Estimates

Nyxoah (NYXH) delivered earnings and revenue surprises of +16.67% and -5.02%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates

Outset Medical (OM) delivered earnings and revenue surprises of -6.25% and +6.65%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Tempus AI (TEM) Beats Q3 Earnings and Revenue Estimates

Tempus (TEM) delivered earnings and revenue surprises of +177.78% and +0.05%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Nyxoah (NYXH) Could be Great Choice for a Bottom Fisher

Nyxoah (NYXH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?

Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial

NYXH initiates its U.S. BREATHE study with the first Genio implant, advancing long-term clinical evidence following FDA approval.

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-market session. The company's market cap stands at $5.6 million.
Nyxoah (NASDAQ:NYXH) shares increased by 12.58% toread more...

INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease

Inspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset weak U.S. procedure activity.

What's Going On With Nyxoah Stock Tuesday?

Nyxoah (NYXH) raises $95M via public offering to fund U.S. commercial growth and Genio system R&D. Stock ticks up in premarket.read more...

FDA Milestones Fueling Expansion

The biotechnology sector delivered several notable developments. $TNGX, $NTHI, $AIM, $AZN, $NRIX, $NYXH

$NYXH Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.20 up 72.97% YoY
• Reported revenue of $10.39M up 349.78% YoY
• Nyxoah expects to continue ramping up sales primarily in the United States; it strives for further growth in Germany, Switzerland, the United Kingdom, the Middle East and select international markets, subject to favourable reimbursement.

Stocktwits

Nyxoah SA

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.20 up 72.97% YoY
• Reported revenue of $10.39M up 349.78% YoY
• Nyxoah expects to continue ramping up sales primarily in the United States; it strives for further growth in Germany, Switzerland, the United Kingdom, the Middle East and select international markets, subject to favourable reimbursement.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

• Reported GAAP EPS of -$0.20 up 72.97% YoY
• Reported revenue of $10.39M up 349.78% YoY
• Nyxoah expects to continue ramping up sales primarily in the United States; it strives for further growth in Germany, Switzerland, the United Kingdom, the Middle East and select international markets, subject to favourable reimbursement.

Nyxoah reported a net loss and operating cash outflows; SG&A increased with commercialization and legal costs, while patent claims seek damages and an injunction and remain in discovery.

Nyxoahs Q3 U.S. sales and revenue were higher than prior-year comparatives; ACCCESS met primary endpoints with no device-related serious adverse events through 12 months, and Genio enables battery-free, leadless bilateral stimulation.

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.

Why Is NYXH Stock Falling Today?

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Nyxoah said it is offering more than 55 million ordinary shares to investors in the U.S. and Europe to raise $95 million.</li><li>Underwriters also have the option to purchase up to an additional 8.3 million ordinary shares at the offering price for up to 30 days.</li><li>On Thursday, the company said it would look for a U.S.-based CEO to ramp up sales of its flagship offering, Genio.</li></ul><p>Shares of Nyxoah (NYXH) were in the spotlight on Friday after the medical technology company disclosed pricing details for the $95 million public offering of its ordinary shares.</p><p>At the time of writing, NYXH stock was down nearly 47% and was on track for its biggest one-day percentage drop ever.</p><h1 class="st-heading-1"><strong>Pricing Of The Offering</strong></h1><p>The company said that it is offering investors in the U.S. and Europe more than 55 million ordinary shares at $1.72 or €1.48 apiece, before underwriting discounts and commissions.</p><p>The USD offer price represents a more than 40% discount to the stock’s last closing price on Thursday, while the EUR offer price is at over a 39% discount to the stock’s trading price on Euronext on Friday. Underwriters also have the option to purchase up to an additional 8.3 million ordinary shares at the offering price for up to 30 days.</p><h1 class="st-heading-1"><strong>Big US Expansion Plans</strong></h1><p>Nyxoah, which makes sleep apnea devices and has primary operations in Belgium, said it will largely use the money to expand commercialization activities in the United States. This comes following its Thursday announcement that it would look for a U.S.-based CEO to ramp up sales of its flagship offering, Genio.</p><p>The money will also be used for Genio research and development, and to advance its launch outside U.S. markets</p><h1 class="st-heading-1"><strong>What Do Retail Traders Think About NYXH?</strong></h1><p>On Stocktwits, retail sentiment about the NYXH stock turned ‘extremely bullish’ from ‘bearish’ over the last 24 hours. One user called the pullback in shares an overreaction.</p><p><stembedurl>https://stocktwits.com/Denzerini/message/655536706</stembedurl></p><p><a href="https://stocktwits.com/symbol/NYXH">NYXH stock</a> has lost more than 67% in value so far this year and more than 80% over the last 12 months, underperforming the benchmark S&amp;P Index.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Stock market down on a black background. (Source: Getty Images))

The company priced its stock offering on Friday at a steep discount, with proceeds to be used to expand commercialization activities in the United States.


Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.8456
Prev Close	$0.811
Open	$0.83
Dividend Yield	0.00%
50-Day Moving Average	$1.27
Beta	1.25
Avg. Volume	227,413.72
PE Ratio	-0.43

52-Week High	$5.92
52-Week Low	$0.80
Market Capitalization	$86.12M
EPS (Annual)	-$2.67
Price to Book	1.12
Revenue Per Employee	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

NYXH Fundamentals